{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-005815","form_type":"8-K","ticker":"EXPO","cik":"0000851520","company_name":"EXPONENT INC","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.155930+00:00","generated_at":"2026-05-30T10:47:48.148419+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Exponent Q3 net income up 6% to $0.50 EPS; revenue flat; raises FY EBITDA margin guidance","bullets":["Q3 revenues before reimbursements $125.1M (flat YoY); net income $26.0M (+6%, $0.50 diluted EPS vs $0.48).","EBITDA margin 28.6% (+100bps); utilization 75% in first nine months.","Engineering segment flat; environmental/health down 6% on chemical/life sciences headwinds.","FY2024 rev growth guided low-to-mid single digits; EBITDA margin raised to 27.9%-28.1%.","Dividend $0.28/share, payable Dec 20, record Dec 6 (unchanged from prior quarter)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-005815","json":"https://secwatch.observer/filing/0001171843-24-005815.json","markdown":"https://secwatch.observer/filing/0001171843-24-005815.md","text":"https://secwatch.observer/filing/0001171843-24-005815.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/851520/000117184324005815/0001171843-24-005815-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/851520/000117184324005815/f8k_102424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:47:48.148419+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}